JP2021523179A5 - - Google Patents

Info

Publication number
JP2021523179A5
JP2021523179A5 JP2020563698A JP2020563698A JP2021523179A5 JP 2021523179 A5 JP2021523179 A5 JP 2021523179A5 JP 2020563698 A JP2020563698 A JP 2020563698A JP 2020563698 A JP2020563698 A JP 2020563698A JP 2021523179 A5 JP2021523179 A5 JP 2021523179A5
Authority
JP
Japan
Prior art keywords
cycloalkyl
alkyl
hydrogen
linear
group
Prior art date
Application number
JP2020563698A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523179A (ja
JP7429652B2 (ja
JPWO2019217890A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/031824 external-priority patent/WO2019217890A1/en
Publication of JP2021523179A publication Critical patent/JP2021523179A/ja
Publication of JPWO2019217890A5 publication Critical patent/JPWO2019217890A5/ja
Publication of JP2021523179A5 publication Critical patent/JP2021523179A5/ja
Priority to JP2024011236A priority Critical patent/JP7629123B2/ja
Application granted granted Critical
Publication of JP7429652B2 publication Critical patent/JP7429652B2/ja
Priority to JP2025013946A priority patent/JP2025061975A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020563698A 2018-05-11 2019-05-10 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法 Active JP7429652B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024011236A JP7629123B2 (ja) 2018-05-11 2024-01-29 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法
JP2025013946A JP2025061975A (ja) 2018-05-11 2025-01-30 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862670116P 2018-05-11 2018-05-11
US62/670,116 2018-05-11
PCT/US2019/031824 WO2019217890A1 (en) 2018-05-11 2019-05-10 Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024011236A Division JP7629123B2 (ja) 2018-05-11 2024-01-29 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法

Publications (4)

Publication Number Publication Date
JP2021523179A JP2021523179A (ja) 2021-09-02
JPWO2019217890A5 JPWO2019217890A5 (https=) 2022-05-17
JP2021523179A5 true JP2021523179A5 (https=) 2022-05-17
JP7429652B2 JP7429652B2 (ja) 2024-02-08

Family

ID=66655471

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020563698A Active JP7429652B2 (ja) 2018-05-11 2019-05-10 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法
JP2024011236A Active JP7629123B2 (ja) 2018-05-11 2024-01-29 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法
JP2025013946A Pending JP2025061975A (ja) 2018-05-11 2025-01-30 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024011236A Active JP7629123B2 (ja) 2018-05-11 2024-01-29 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法
JP2025013946A Pending JP2025061975A (ja) 2018-05-11 2025-01-30 5-ヒドロキシトリプタミン受容体7の調節物質としての新規官能化ラクタムおよびその使用方法

Country Status (14)

Country Link
US (3) US12559494B2 (https=)
EP (1) EP3790859A1 (https=)
JP (3) JP7429652B2 (https=)
KR (1) KR20210020182A (https=)
CN (2) CN112437768B (https=)
AU (2) AU2019267846B2 (https=)
BR (1) BR112020023072A2 (https=)
CA (1) CA3110799A1 (https=)
EA (1) EA202092328A1 (https=)
IL (3) IL317778A (https=)
MA (1) MA52567A (https=)
MX (2) MX2020012030A (https=)
TW (2) TW202523659A (https=)
WO (1) WO2019217890A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970223B1 (en) 2013-03-11 2020-04-15 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
AU2017361078B2 (en) 2016-11-15 2022-01-06 Praeventix, Llc Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use
MA49019A (fr) 2017-03-21 2020-02-05 Univ Temple Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation
MA49017A (fr) 2017-03-21 2020-02-05 Univ Temple Modulateurs du récepteur 7 de la 5-hydroxytryptamine et utilisation de ces derniers en tant qu'agents thérapeutiques
EA202092328A1 (ru) 2018-05-11 2021-04-08 Темпл Юниверсити-Оф Зэ Коммонвелс Систем Оф Хаер Эдьюкейшн Новые функционализированные лактамы в качестве модуляторов 5-гидрокситриптаминового рецептора 7 и способ их применения
GB201809295D0 (en) * 2018-06-06 2018-07-25 Institute Of Cancer Res Royal Cancer Hospital Lox inhibitors
JP7730811B2 (ja) * 2019-11-13 2025-08-28 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 5-ヒドロキシトリプタミン受容体7の調節因子としての新規官能化ラクタムおよびその使用方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2647785B1 (fr) * 1989-05-31 1991-09-06 Adir Nouveaux derives de la pyrrolidone, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9912701D0 (en) * 1999-06-01 1999-08-04 Smithkline Beecham Plc Novel compounds
CA2440803A1 (en) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
JP4203235B2 (ja) 2001-07-05 2008-12-24 日本板硝子株式会社 ガラスパネル
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
MXPA05008137A (es) 2003-01-31 2005-09-30 Pfizer Prod Inc Antagonistas y agonistas de 5ht7.
JP2006025227A (ja) 2004-07-08 2006-01-26 Sony Corp 情報処理装置、情報処理方法、およびプログラム、並びに記録媒体
EP1875899A1 (en) 2006-06-29 2008-01-09 Laboratorios Del Dr. Esteve, S.A. Use of 5HT7 receptor agonists for the treatment of pain
CA2699674C (en) 2007-10-12 2013-07-16 Eli Lilly And Company 5-ht7 receptor antagonists
EP2341912B1 (en) 2008-09-05 2014-01-22 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
WO2010069390A1 (en) 2008-12-19 2010-06-24 Nokia Siemens Networks Oy Method and device for data processing in an udwdm network and communication system comprising such device
GB201002563D0 (en) 2010-02-15 2010-03-31 Cambridge Entpr Ltd Compounds
US20130287705A1 (en) 2010-11-03 2013-10-31 Mcmaster University Method of treating mucosal inflammation
CN103570722A (zh) 2012-07-19 2014-02-12 中国科学院上海药物研究所 稠环哒嗪酮类化合物及其制备方法和用途
WO2014085413A1 (en) 2012-11-28 2014-06-05 Temple University - Of The Commonwealth System Of Higher Education Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators
EP2970223B1 (en) * 2013-03-11 2020-04-15 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US20180221365A1 (en) 2015-05-12 2018-08-09 Temple University-Of The Commonwealth System Of Higher Education Novel sigma-2 receptor binders and their method of use
AU2017361078B2 (en) 2016-11-15 2022-01-06 Praeventix, Llc Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use
MA49019A (fr) * 2017-03-21 2020-02-05 Univ Temple Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation
MA49017A (fr) * 2017-03-21 2020-02-05 Univ Temple Modulateurs du récepteur 7 de la 5-hydroxytryptamine et utilisation de ces derniers en tant qu'agents thérapeutiques
EA202092328A1 (ru) 2018-05-11 2021-04-08 Темпл Юниверсити-Оф Зэ Коммонвелс Систем Оф Хаер Эдьюкейшн Новые функционализированные лактамы в качестве модуляторов 5-гидрокситриптаминового рецептора 7 и способ их применения
CN110272425B (zh) 2018-07-02 2022-11-04 广东东阳光药业有限公司 吡啶酰基八氢吡咯并[3,4-c]吡咯衍生物及其用途
WO2021097117A2 (en) 2019-11-13 2021-05-20 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactones as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
JP7730811B2 (ja) 2019-11-13 2025-08-28 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 5-ヒドロキシトリプタミン受容体7の調節因子としての新規官能化ラクタムおよびその使用方法

Similar Documents

Publication Publication Date Title
JP2021523179A5 (https=)
RU2003105900A (ru) Производные 4,5-дигидро-1h-пиразола, обладающие cb1-антагонистической активностью
JP2010533715A5 (https=)
IL317778A (en) New functional agonists as modulators of 5-hydroxytryptamine receptor 7 and a method for their production
JP7621289B2 (ja) ベンゾジアゼピン系化合物及びその製造方法並びに医薬における作用
IL274504B2 (en) Acss2 inhibitors and methods of use thereof
CA2422708A1 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
RU2018104278A (ru) Оксистеролы и способы их применения
JP2004518763A5 (https=)
JP2009542720A5 (https=)
RS51066B (sr) Supstituisani derivati morfolina i tiomorfolina
RU2001123126A (ru) Производные пиридопираноазепинов, их получение и терапевтическое применение
JPWO2010110353A1 (ja) 新規アミド誘導体および美白剤
CA2372063A1 (en) Pyridopyranoazepine derivatives, their preparation and their therapeutic application
EA200501615A1 (ru) (2-гидрокси-2-(4-гидрокси-3-гидроксиметилфенил)этиламино)пропилфенильные производные в качестве бета-2-агонистов
JP2025160211A (ja) Kv7カリウムチャネル開口薬としてのアルコール誘導体
JPWO2019217890A5 (https=)
AU776968B2 (en) Indole derivatives
JP2018538355A (ja) ベンズアミド誘導体
TW200906814A (en) Method for manufacture of escitalopram
CA2211981C (en) Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols
RU2007136783A (ru) ГИДРАЗИНОКАРБОНИЛТИЕНО[2, 3-c]ПИРАЗОЛЫ, СПОСОБ ПОЛУЧЕНИЯ, СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ
JP2003012648A (ja) 5ht7受容体アゴニスト活性を有する4−(2−ピリジル)ピペリジン類
JP2007508314A5 (https=)
JP2003528098A5 (https=)